Wilkinson Distinguished Lecture to be Thursday, April 7
Alan Shuldiner, M.D., a pioneer in genomic medicine, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Thursday, April 7.
Shuldiner is founding director of the Program for Personalized and Genomic Medicine at the University of Maryland School of Medicine, and vice president and co-head of the Regeron Genetics Center, part of Regeron Pharmaceuticals Inc., in Tarrytown, New York.
His lecture, entitled “The path to precision medicine, from discovery to implementation into patient care,” will begin at 8 a.m. in 208 Light Hall.
Shuldiner has made several important discoveries regarding the genetics of age-related diseases including diabetes, obesity, osteoporosis and cardiovascular disease. He is best known for his research in the Old Order Amish, a homogeneous founder population ideal for genetic studies.
The endowed Wilkinson lectureship is named for the late Grant R. Wilkinson, Ph.D., D.Sc., a distinguished Vanderbilt clinical pharmacologist.
The lecture is sponsored by the Division of Clinical Pharmacology, the Departments of Medicine and Pharmacology and Vanderbilt University School of Medicine.